Baumal Caroline 4

What Happened

• Caroline Baumal, Chief Medical Officer of Apellis Pharmaceuticals (APLS), sold 1,882 shares in a sale reported for January 20, 2026. The shares were disposed at $19.79 each for a total of approximately $37,250. This was a sale (not a purchase) and was done to satisfy tax withholding related to Restricted Stock Units (RSUs) that vested on January 16, 2026.

Key Details

• Transaction date and price: 2026-01-20 at $19.79 per share.
• Shares sold: 1,882; proceeds ≈ $37,250.
• Transaction type: Sale (open market or private sale as reported).
• Footnote: Sale executed to cover tax withholding on RSUs released Jan 16, 2026 (per filing note F1).
• Shares owned after transaction: Not specified in the provided filing details.
• Filing timeliness: No late filing indicated in the provided data.

Context

• Sales to cover tax withholding on RSU vesting are routine and do not necessarily indicate a change in insider confidence. They are administrative transactions to satisfy tax obligations rather than discretionary market-timing trades.